We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
+5.55%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$5.86B
AUM Growth
+$813M
(+16%)
Cap. Flow
+$544M
Cap. Flow
% of AUM
9.28%
Top 10 Holdings %
Top 10 Hldgs %
50.44%
Holding
3,726
New
379
Increased
1,205
Reduced
834
Closed
278
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$68.1M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$66.4M |
| 3 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$59M |
| 4 |
Vanguard Mid-Cap ETF
VO
|
+$49.9M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$26.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$77.7M |
| 2 |
Vanguard Total International Bond ETF
BNDX
|
+$5.23M |
| 3 |
WisdomTree Emerging Markets Local Debt Fund
ELD
|
+$3.78M |
| 4 |
Invesco Preferred ETF
PGX
|
+$3.67M |
| 5 |
Nuveen Municipal High Income Opportunity Fund
NMZ
|
+$2.76M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 6.93% |
| 2 | Financials | 4.55% |
| 3 | Technology | 3.35% |
| 4 | Industrials | 2.51% |
| 5 | Healthcare | 2.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Salesforce
CRM
$134B
| $852K | 0.01% |
15,443
+1,627
| +12% | +$87K |
|
352
iShares Intermediate Government/Credit Bond ETF
GVI
$3.72B
| $849K | 0.01% |
7,763
-455
| -6% | -$50.1K |
|
|
ALXN
353
DELISTED
Alexion Pharmaceuticals
ALXN
| $847K | 0.01% |
6,376
-737
| -10% | -$88.4K |
|
|
HERO
354
DELISTED
HERCULES OFFSHORE INC COM STK
HERO
| $846K | 0.01% |
129,686
+126,001
| +3,419% | +$850K |
|
355
PNC Financial Services
PNC
$100B
| $845K | 0.01% |
10,889
+1,312
| +14% | +$98.4K |
|
356
Donaldson
DCI
$10.8B
| $840K | 0.01% |
19,336
+800
| +4% | +$32.6K |
|
|
TWC
357
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $838K | 0.01% |
6,185
+2,077
| +51% | +$258K |
|
|
KSU
358
DELISTED
Kansas City Southern
KSU
| $837K | 0.01% |
6,756
+1,905
| +39% | +$228K |
|
359
Vanguard S&P 500 ETF
VOO
$968B
| $832K | 0.01% |
4,920
+1,236
| +34% | +$200K |
|
360
FirstEnergy
FE
$28.9B
| $829K | 0.01% |
25,132
+2,532
| +11% | +$89.2K |
|
361
Thermo Fisher Scientific
TMO
$211B
| $828K | 0.01% |
7,437
+536
| +8% | +$53.3K |
|
|
MHFI
362
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
| $827K | 0.01% |
10,574
+271
| +3% | +$19.5K |
|
363
Ameren
AEE
$31.5B
| $816K | 0.01% |
22,561
+4,538
| +25% | +$163K |
|
364
MGM Resorts International
MGM
$11.7B
| $808K | 0.01% |
34,351
+14,470
| +73% | +$295K |
|
|
MCI
365
Barings Corporate Investors
MCI
$340M
| $798K | 0.01% |
53,471
-252
| -0.5% | -$3.74K |
|
366
Core Laboratories
CLB
$538M
| $795K | 0.01% |
4,164
+41
| +1% | +$7.63K |
|
|
NVO
367
Novo Nordisk
NVO
$216B
| $793K | 0.01% |
42,890
+11,360
| +36% | +$198K |
|
368
Prospect Capital
PSEC
$1.06B
| $792K | 0.01% |
70,588
+16,713
| +31% | +$188K |
|
369
Diageo
DEO
$46.2B
| $788K | 0.01% |
5,950
+1,090
| +22% | +$139K |
|
370
Transocean
RIG
$5.92B
| $787K | 0.01% |
15,925
-9,695
| -38% | -$474K |
|
371
Rollins
ROL
$18.6B
| $784K | 0.01% |
87,345
-4,050
| -4% | -$33.7K |
|
|
FGP
372
DELISTED
Ferrellgas Partners, L.P.
FGP
| $784K | 0.01% |
34,170
+455
| +1% | +$10.5K |
|
373
Sempra
SRE
$60.8B
| $780K | 0.01% |
17,368
-5,762
| -25% | -$256K |
|
374
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.22B
| $776K | 0.01% |
13,090
+252
| +2% | +$14.3K |
|
375
iShares China Large-Cap ETF
FXI
$4.31B
| $774K | 0.01% |
20,177
+6,735
| +50% | +$257K |
|
Similar funds
Creative Planning's Q4 2013 Portfolio in Review
As of Q4 2013, Creative Planning held 3,726 positions worth $5.86B, up 16% from $5.04B the previous quarter. Its ten largest holdings account for 50% of the portfolio.
Creative Planning deployed $544M of net new capital in Q4 2013, opening 379 new positions and adding to 1,205 existing holdings. Its largest new stake was Allergan plc: 7,924 shares worth $1.33M.
By sector, the portfolio is most concentrated in Energy at 6.9% of assets, up from 6.3% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vanguard Intermediate-Term Corporate Bond ETF, an estimated $77.7M trimmed.
- Creative Planning's largest Q4 2013 buy was Allergan plc: 7,924 shares worth $1.33M.
- Creative Planning added most to Vanguard FTSE Developed Markets ETF in Q4 2013, an estimated $68.1M increase.
- Creative Planning's biggest Q4 2013 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $77.7M.
- Creative Planning fully exited Pioneer Municipal High Income Advantage Fund in Q4 2013, selling an estimated $1.95M.
- Creative Planning's ten largest holdings make up 50% of its $5.86B portfolio in Q4 2013.
- Creative Planning opened 379 new positions and closed 278 in Q4 2013.
- Creative Planning's portfolio value rose 16% quarter-over-quarter to $5.86B.
Based on Creative Planning's 13F filing for Q4 2013, filed 6 Jan 2014.